Crossmark

The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients

Crossref DOI link: https://doi.org/10.1186/s12885-018-4987-0

Published Online: 2018-11-07

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Ping

Zhou, Mingyi

Qu, Jinglei

Fu, Lingyu

Li, Xuedan

Cai, Ruimei

Jin, Bo

Teng, Yuee

Liu, Jing

Shi, Jing

Zhang, Jingdong http://orcid.org/0000-0002-0711-2764
Funding

Funding for this research was provided by:

the Educational Commission of Liaoning Province of China (20060973)

the Science and Technology Planning Project of Liaoning Province of China (2007225009-1, 2011404013-9, 2011225019, 2013225079)

the National Natural Science Foundation of China (81372532)

the Science and Technology Planning Project of Shenyang (F15-139-9-27)

the scientific research foundation for the introduction of talents, Liaoning Cancer Hospital & Institute
License Information

Text and Data Mining valid from 2018-11-07
More Information

Article History

Received: 11 January 2018

Accepted: 23 October 2018

First Online: 7 November 2018

Ethics approval and consent to participate

: This retrospective study was compliant with the Declaration of Helsinki, and was approved by the Ethics Committee of the First Hospital of China Medical University (No.201581). Informed consent was obtained for each patient. And the privacy rights of patients were observed.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.